Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mohamed A. Alm El-Din"'
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 65, Iss 2, Pp 527-530 (2016)
Background: Radiotherapy and chemotherapy are the standard palliative treatments in patients with inoperable carcinoma of the lung present with obstruction of the central airway but have limited effectiveness in reopening obstructed airways. Cryosurg
Externí odkaz:
https://doaj.org/article/88041fd3181e4062a64da64b673c0879
Publikováno v:
Saudi Medical Journal. 43:37-44
To investigate the anti-tumor activity and tolerability of celecoxib as an adjuvant therapy for patients with metastatic colorectal cancer (CRC).In this randomized controlled study, 54 patients with metastatic CRC were randomized into 2 groups; the c
Autor:
Neveen A. Kohaf, Mohamed M.M. Abdel-Latif, Mohamed A. Alm El-Din, Hosny A. Elewa, Zeinab Alkasaby Zalat
Publikováno v:
Azhar International Journal of Pharmaceutical and Medical Sciences. 1:15-23
Silymarin ‘milk thistle’ (Silybum marianum) plant, has been used for years for treatment of different diseases such as liver and gallbladder disorders, protecting liver against snake bite and insect stings, mushroom poisoning and alcohol abuse. S
Autor:
Hosny A. Elewa, Mohamed A. Alm El-Din, Neeven A. Kohaf, Zeinab Alkasaby Zalat, Mohamed M.M. Abdel-Latif
Publikováno v:
Journal of Bioscience and Applied Research. :190-206
Aim: Anthracycline-induced cardiotoxicity is the most common constraint of its use in the treatment of various types of cancer. This study aimed to investigate the benefits of the addition of the l-carnitine / silymarin to anthracycline chemotherapy
Autor:
Zeinab Alkasaby Zalat, Badriyah Shadid Alotaibi, Hosny A. Elewa, Mohamed A. Alm El-Din, Neveen A. Kohaf, Mohamed M.M. Abdel-Latif
Publikováno v:
Journal of Medical and Life Science. :20-38
Objectives: To investigate changes after adding L-carnitine and silymarin compared to anthracycline chemotherapy alone on the health-related quality of life (HRQoL) of women with breast cancer receiving anthracycline-based chemotherapy. Methods: A pr
Autor:
Lior Z. Braunstein, Brian Napolitano, Tessa C Gillespie, Mohamed Abouegylah, Alphonse G. Taghian, Mohamed Farouk, Laura Salama, K. Remillard, Abdelsalam A. Ismail, Andrzej Niemierko, Steve Edgington, George E. Naoum, Hoda E. Sayegh, Mohamed A. Alm El-Din, Mostafa Elebrashi
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Patients with Her2-positive breast cancer treated with trastuzumab have higher rates of cardiotoxicity (CT). Left-breast radiation might increase the risk for CT from cardiac exposure to radiation. The goal of our study is to evaluate the co
Publikováno v:
African Journal of Microbiology Research. 12:947-952
This work aimed at the phenotypic and molecular characterization of inducible clindamycin resistance among strains of Staphylococcus aureus isolated from cancer patients with febrile neutropenia. Out of 231clinical specimens Staphylococci were isolat
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 65, Iss 2, Pp 527-530 (2016)
Background Radiotherapy and chemotherapy are the standard palliative treatments in patients with inoperable carcinoma of the lung present with obstruction of the central airway but have limited effectiveness in reopening obstructed airways. Cryosurge
Autor:
Anne Lanceley, Susanne Singer, Heike Schmidt, Hans-Henning Flechtner, Krzysztof A. Tomaszewski, Thierry Conroy, Wei-Chu Chie, Dirk Hofmeister, Bernhard Holzner, Joachim Weis, Markus Wirtz, Louise Jones, Eva Hammerlid, Andrew Bottomley, Mohamed A. Alm El-Din, Amelie Harle, Inge Compter, Monica Pinto, Marek Czeladzki, Juan Ignacio Arraras, Sabrina Ritter
Publikováno v:
Journal of the National Cancer Institute, 109(5):273. Oxford University Press
Background: The European Organisation for Research and Treatment of Cancer (EORTC) Group has developed a new multidimensional instrument measuring cancer-related fatigue to be used in conjunction with the quality of life core questionnaire (EORTC QLQ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9fb3f7b4e13307ec69c8e1e944f0335
https://cris.maastrichtuniversity.nl/en/publications/ade58830-360b-4d20-b3cb-74ca47ea2ad3
https://cris.maastrichtuniversity.nl/en/publications/ade58830-360b-4d20-b3cb-74ca47ea2ad3
Autor:
Gemma Cramarossa, Alysa Fairchild, Liang Zeng, Fabien Forges, Ming-Feng Hou, Edward Chow, Henry Lam, Reynaldo Jesus-Garcia, Mohamed A. Alm El-Din, Wei-Chu Chie, Vassilios Vassiliou, Liying Zhang, Natalie Pulenzas, Arjun Sahgal, Aswin Kumar, Ling-Ming Tseng
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 14:139-146
To identify which domains/symptoms from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) were predictive of overall quality of life (QoL) in advanced cancer patients.Four hundred and forty s